Valuation: Aspen Pharmacare Holdings Limited

Market Cap 70.77B 4.25B 3.8B 3.54B 3.22B 6.06B 411B 6.11B 42.59B 16.64B 209B 15.96B 15.62B 672B P/E 2026
26.3x
P/E 2027 * 14.6x
Enterprise Value 83.65B 5.03B 4.49B 4.19B 3.81B 7.17B 486B 7.22B 50.34B 19.67B 247B 18.87B 18.46B 795B EV / Sales 2026
-
EV / Sales 2027 * 1.85x
Free-Float
58.39%
Yield 2026
1.48%
Yield 2027 * 1.55%
1 day+1.19%
1 week+0.56%
Current month+2.25%
1 month+7.62%
3 months+3.45%
6 months+20.72%
Current year+38.62%
1 week 156.45
Extreme 156.45
161.97
1 month 150.74
Extreme 150.74
166.21
Current year 104.38
Extreme 104.38
166.21
1 year 90.7
Extreme 90.7
166.21
3 years 90.7
Extreme 90.7
252.96
5 years 90.7
Extreme 90.7
255.37
10 years 64.07
Extreme 64.07
327.5
Manager TitleAgeSince
Chief Executive Officer 62 01/01/1997
Director of Finance/CFO 61 01/01/2009
Chief Operating Officer 63 01/01/1999
Director TitleAgeSince
Director/Board Member 62 01/01/1999
Director/Board Member 65 01/01/1999
Chairman 58 07/12/2015
Date Insider Type Main position Quantity % Market Cap. Importance
27/09/23 Free

Chief Operating Officer

12,236 0.0027%
27/09/23 Free

Executive/Senior Manager

11,728 0.0026%
27/09/23 Free

Founder

10,558 0.0024%
Change 5-day change 1-year change 3-year change Capi.($)
+1.19%+0.56%+66.91%-5.87% 4.25B
+2.70%+2.73%+40.91%+110.31% 1,060B
+1.44%-2.38%+36.83%+63.95% 623B
+1.75%+3.73%+16.55%+83.05% 480B
+0.60%-1.73%+62.98%+37.46% 352B
-1.50%+1.38%+21.46%+41.04% 345B
-1.12%+0.42%+11.32%+34.53% 274B
-1.12%-1.89%-5.73%+10.98% 249B
+2.60%-2.00%+39.77%+54.44% 223B
+1.82%-1.48%+25.75%+96.48% 182B
Average -0.32%-0.21%+31.67%+52.64% 379.23B
Weighted average by Cap. -0.35%+0.04%+31.47%+70.09%

Financials

2026 2027 *
Net sales 37.62B 2.26B 2.02B 1.88B 1.71B 3.22B 219B 3.25B 22.64B 8.85B 111B 8.48B 8.3B 357B 37.04B 2.23B 1.99B 1.85B 1.68B 3.17B 215B 3.2B 22.29B 8.71B 109B 8.35B 8.17B 352B
Net income 4.8B 288M 258M 240M 218M 411M 27.88B 414M 2.89B 1.13B 14.18B 1.08B 1.06B 45.59B 4.77B 287M 256M 239M 217M 409M 27.72B 412M 2.87B 1.12B 14.1B 1.08B 1.05B 45.32B
Net Debt 12.88B 774M 691M 645M 586M 1.1B 74.84B 1.11B 7.75B 3.03B 38.06B 2.9B 2.84B 122B -2.41B -145M -130M -121M -110M -207M -14.03B -208M -1.45B -568M -7.13B -544M -533M -22.94B
Projected Income Statement - Annual - Aspen Pharmacare Holdings Limited
Logo Aspen Pharmacare Holdings Limited
Aspen Pharmacare Holdings Limited is the African leading pharmaceutical group. The group's products are primarily for the treatment of asthma, HIV, bacterial infections, gastro-intestinal, respiratory and inflammatory diseases. Net sales break down by family of products as follows: - pharmaceuticals (68.4%): anaesthetics products, thrombosis products, cytotoxic products, etc.; - other (31.6%): infant nutrition products and consumer products. At the end of June 2024, the group had 24 production sites worldwide.
Employees
9,343
Date Price Change Volume
07/10/26 ZAR 159.38 -1.56% 1,457,665
06/10/26 ZAR 161.90 +1.19% 1,551,865
05/10/26 ZAR 159.99 -0.01% 839,639
02/10/26 ZAR 160.00 +0.98% 1,225,558
01/10/26 ZAR 158.45 +0.07% 1,049,510
Trader
Investor
Global
Quality
ESG MSCI
A
Ratings Surperformance© - Aspen Pharmacare Holdings Limited
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
159.38ZAR
Average target price
172.67ZAR
Spread / Average Target
+8.34%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Aspen Pharmacare Holdings Limited